Trial Outcomes & Findings for Aspirin Responsiveness in Women With Coronary Artery Disease (NCT NCT01406990)

Results Overview

Hyporesponsive was defined as Aspirin Response Unit (ARU) \> 550 equating to less than 50% platelet inhibition.

Recruitment status

COMPLETED

Target enrollment

15 participants

Primary outcome timeframe

Time of enrollment

Results posted on

2012-09-28

Participant milestones
Measure	Aspirin 81 mg Women with CAD taking 81 mg aspirin.
Overall Study STARTED	15
Overall Study COMPLETED	15
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Aspirin Responsiveness in Women With Coronary Artery Disease

Baseline characteristics by cohort
Measure	Aspirin 81 mg n=15 Participants Women with CAD taking 81 mg aspirin.
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	2 Participants n=5 Participants
Age, Categorical >=65 years	13 Participants n=5 Participants
Age Continuous	71.8 years STANDARD_DEVIATION 6.13 • n=5 Participants
Sex: Female, Male Female	15 Participants n=5 Participants
Sex: Female, Male Male	0 Participants n=5 Participants
Region of Enrollment United States	15 participants n=5 Participants

Timeframe: Time of enrollment

Hyporesponsive was defined as Aspirin Response Unit (ARU) \> 550 equating to less than 50% platelet inhibition.

Outcome measures
Measure	Aspirin 81 mg n=15 Participants Women with CAD taking 81 mg aspirin.
Women With Known CAD Who Are Hyporesponsive to Low Dose (81 mg) Aspirin	0 participants

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Creighton University

Phone: 402-280-4566